Comparisons

Henry Meds vs Ozari: An Honest Comparison of GLP-1 Weight Loss Programs

If you're exploring GLP-1 medications like semaglutide or tirzepatide for weight loss, you've likely come across both Henry Meds and Ozari Health. Both companies offer telehealth access to these powerful medications, but they take different approaches to pricing, support, and patient care. Understanding these differences can help you choose the option that best fits your needs and budget.

Let's take an honest look at how these two services compare, so you can make the most informed decision for your health journey.

What Both Companies Have in Common

Before diving into differences, it's worth noting what Henry Meds and Ozari share. Both are legitimate telehealth platforms that connect you with licensed healthcare providers who can prescribe compounded GLP-1 medications. Both offer semaglutide and tirzepatide, the active ingredients found in brand-name medications like Wegovy and Zepbound.

Each company ships medications directly to your door and eliminates the need for in-person doctor visits. This convenience has made telehealth weight loss programs increasingly popular, especially for busy adults juggling work, family, and health goals.

Pricing: Where the Biggest Differences Emerge

Henry Meds Pricing Structure

Henry Meds uses a tiered pricing model that changes based on your dosage level. Starting prices typically begin around $297 per month for lower doses of semaglutide, with costs increasing as you move to higher maintenance doses. Tirzepatide options generally start higher, often in the $350-$450 range monthly.

While Henry Meds occasionally runs promotional pricing, the standard costs can add up significantly over time, especially once you reach therapeutic doses needed for sustained weight loss.

Ozari's Straightforward Pricing

Ozari takes a different approach with flat-rate pricing at $99 per month for compounded semaglutide or tirzepatide, regardless of dose. This transparent pricing means you won't face surprise cost increases as your treatment progresses. What you pay in month one is what you'll pay in month six.

For many people, especially those planning long-term treatment, this predictability makes budgeting easier and keeps weight loss medication accessible throughout their journey.

Medication Options and Quality

Both Henry Meds and Ozari provide compounded versions of semaglutide and tirzepatide through FDA-registered 503B compounding pharmacies. These are not the brand-name medications, but they contain the same active ingredients and work through the same mechanisms.

Compounded medications have become the go-to option for many patients because they offer significant cost savings compared to brand-name versions that can cost $1,000 or more monthly without insurance coverage.

Both companies adjust dosages based on your individual response and tolerance, following established clinical protocols. The medications themselves are comparable in quality between the two services.

The Patient Experience

Getting Started

Henry Meds and Ozari both begin with an online intake process where you provide medical history and current health information. A licensed physician reviews your information to determine if GLP-1 therapy is appropriate for you.

The approval process is typically quick with both services, often within 24-48 hours. If approved, your medication ships directly to your address.

Ongoing Support and Communication

This is where experiences can vary. Henry Meds offers access to their care team primarily through messaging, with response times that can vary based on volume.

Ozari emphasizes physician-led care with a clinical team that remains accessible throughout your treatment. The focus is on making sure you feel supported not just at signup, but through the ongoing adjustments and questions that naturally arise during weight loss treatment.

A Note on Gender Differences

While both men and women use GLP-1 medications successfully, women may experience different side effects or dosing needs, particularly around menstrual cycles or menopause. Some women report that hormonal fluctuations affect their response to these medications.

Regardless of which service you choose, it's important to work with providers who understand these nuances. Don't hesitate to communicate how your body is responding, including any patterns you notice related to your cycle or hormonal changes.

What to Consider When Choosing

Your decision between Henry Meds and Ozari should factor in several personal considerations:

The Bottom Line

Both Henry Meds and Ozari provide legitimate pathways to GLP-1 medications for weight loss. Henry Meds has been in the space longer and offers a structured program with tiered pricing. Ozari distinguishes itself through transparent, affordable flat-rate pricing and a physician-forward care approach.

For most people, especially those committed to long-term treatment, Ozari's pricing structure offers better value. The $99 monthly cost remains consistent regardless of dosage, making it one of the most accessible options currently available.

Ultimately, the best choice is the one you can stick with consistently. Weight loss with GLP-1 medications requires months of treatment, and affordability matters just as much as initial access.

From the Ozari Care Team

One of the most important factors in GLP-1 therapy success isn't the medication itself—it's consistency. We see the best outcomes in patients who can maintain treatment for at least six months without interruption. When choosing a provider, prioritize one you can afford long-term over the lowest possible starting price.

Ready to Start Your Journey?

At Ozari Health, we offer compounded semaglutide and tirzepatide as low as $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically Reviewed — Ozari Clinical Content Team (OCCT). Health writers and wellness professionals specializing in GLP-1 therapy, metabolic health, and weight loss medicine. Content reviewed in accordance with Ozari's Editorial Standards. Last reviewed: April 25, 2026.

This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.

Last reviewed: April 25, 2026